Dr. DaSilva is a tenured Associate Professor in the Department of Biologic & Materials Sciences at the University of Michigan School of Dentistry (U-M SOD). He received his D.Med.Sc. degree in Oral Biology with clinical training in Orofacial Pain at Harvard University. He is the Founder and Director of the H.O.P.E. (Headache & Orofacial Pain Effort) laboratory, a multidisciplinary collaborative effort at the University of Michigan to investigate the brain as a research and therapeutic target for pain. The H.O.P.E. Laboratory focuses on the development of clinical and neuroscience-driven technology innovations for human neuroimaging, neuromodulation, mobile technology, telemedicine, artificial intelligence, augmented/virtual reality, and their integration for pain research, education, and treatment. Dr.DaSilva has been a frequent speaker at scientific meetings such as the International Association for the Study of Pain, American Academy of Orofacial Pain, American Headache Society, American Pain Society, National Institutes of Health (NIH), and educational initiatives of the National Science Foundation. He is the principal investigator of several NIH, foundation and industry grants on the evaluation and modulation of opioid and cortical mechanisms in the brains of chronic pain patients in vivo, including TMD, migraine, dental pain and cancer pain. His publications have received broad media coverage by national and international venues; for example, Discovery Channel, Los Angeles Times, USA Today, San Francisco Chronicle, Scientific American’s Mind, and others.